Systematic Evaluation of Paired Primary and Recurrent Gliomas Identifies Key Genetic Markers for Survival and Therapeutic Targets
Wei Yu(University of California, Los Angeles), Qichun Wei(Ministry of Education of the People's Republic of China), Zhanhuai Wang(MRC Laboratory of Molecular Biology), Yanqin Huang(Zhejiang University), Yongjie Shu(First Affiliated Hospital Zhejiang University), Yinglu Guo, Xianglong Li(First Affiliated Hospital Zhejiang University), Jing Xu(XinHua Hospital), Zexin Chen(First Affiliated Hospital Zhejiang University), Jinghong Xu(First Affiliated Hospital Zhejiang University), YU Xiao-fang(Ministry of Education), Juan Zhou(Unknown), Xiaoqiu Ren(Zhejiang University), Bicheng Zhang(University of Electronic Science and Technology of China)
Cited by 0
Related Papers
Clinical characteristics of 82 cases of death from COVID-19
|PLoS ONE|2020|594
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
|Frontiers in Molecular Biosciences|2020|497
Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019
|Clinical Infectious Diseases|2020|458
Single cell transcriptomics identifies a unique adipose lineage cell population that regulates bone marrow environment
|eLife|2020|347
Anti-angiogenic Agents in Combination With Immune Checkpoint Inhibitors: A Promising Strategy for Cancer Treatment
|Frontiers in Immunology|2020|256